Since its founding in 2008 , BioSplice ( formerly Samumed ) has had a unique operating philosophy based on building a broad technology platform for modulating regenerative pathways to improve patient health .

To address degenerative diseases , one of BioSplice ’ s primary signaling pathways is the Wnt pathway , which regulates the self-renewal and differentiation of adult stem cells . “ The ability to modulate the Wnt pathway , and thereby recover and restore the health of diseased tissues , presents significant opportunities in regenerative therapeutics ,” says BioSplice .

CEO : Jason Kelly

Believing that biology is “ the best manufacturing technology on the planet ,” Ginkgo Bioworks collaborates with its partners and ecosystems , to automate and scale the organism engineering process , providing engineers with the ability to prototype thousands of biological designs .

Ginkgo Bioworks ’ five areas of expertise include strain improvement , enzyme discovery , new product development , biosecurity , and mammalian cell engineering .

“ The interesting thing to program in the 21st century isn ’ t going to be computers - it ’ s biology ,” says Tom Knight , Co-Founder of Ginkgo Bioworks .

154 May 2021